Brazilian Research: Topamax in Low-dose Drug Combo Soothes Migraines with Less Toxicity
According to Brazilian research, patients who take Topamax in lower doses along with sodium divalproate can still find it to be an effective treatment against migraine prophylaxis. This may sound...
Ongoing Study: Babies Exposed to Valproate In Utero May Suffer from Impaired IQ
It turns out that Topamax isn’t the only epilepsy medication that can cause serious adverse side effects to babies. Researchers in the U.S. and U.K. are currently conducting an ongoing...
CJF Warns Public to be Watchful of Topamax Glaucoma Label Warning
The Consumer Justice Foundation (CJF), which exists to alert the public about the dangers of certain medications, has announced yet another alert for the public, this time about the epilepsy...
Vimpat Data Will be Presented at AES Annual Meeting
UCB, a leading biopharmaceutical company, is committed to helping develop new treatments for epilepsy. The company is sponsoring several key sets of Vimpat (also known as lacosamide) C-V information at...
Study: Patients Taking Older Epilepsy Drugs at Risk for Atherosclerosis
A new study is showing that epileptic patients taking older antiepileptic drugs (AEDs) for long periods of time are at risk of developing atherosclerosis — commonly known as a hardening...